RA Capital Healthcare Fund LP
10% Owner; Director; Director, 10% Owner · 67 filings · Latest: Oct 5, 2026
Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Freenome, Inc.
Hemab Therapeutics Holdings, Inc.
Inhibikase Therapeutics, Inc.
Janux Therapeutics, Inc.
LENZ Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Nkarta, Inc.
Parabilis Medicines, Inc.
PepGen Inc.
Prelude Therapeutics Inc
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
Tyra Biosciences, Inc.
Vor Biopharma Inc.
Wave Life Sciences, Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SION | RA Capital Healthcare Fund LP | — | Oct 28, 2025 | Proposed Sale | $39.45 | 3,624 | $143.0K | — | |
SION | RA Capital Healthcare Fund LP | — | Oct 24, 2025 | Proposed Sale | $39.21 | 14,116 | $553.5K | — | |
VOR | RA Capital Healthcare Fund LP | — | Oct 20, 2025 | Proposed Sale | $29.43 | 76,919 | $2.3M | — | |
VOR | RA Capital Healthcare Fund LP | — | Oct 17, 2025 | Proposed Sale | $29.00 | 218,043 | $6.3M | — | |
VOR | RA Capital Healthcare Fund LP | — | Oct 16, 2025 | Proposed Sale | $29.06 | 126,887 | $3.7M | — | |
VOR | RA Capital Healthcare Fund LP | — | Oct 15, 2025 | Proposed Sale | $30.22 | 42,933 | $1.3M | — |
← Previous
Page 5 of 5